Delivery Order SPE2DB22D3004-SPE2DB24FPR49
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,947.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This federal contract award, SPE2DB22D3004|SPE2DB25FPF74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies, with a ceiling value of $10,947.00 and a period of performance through February 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award SPE2DB20D3103|SPE2DB24FN4E4, valued at $10,581.60, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product. This award is a firm fixed price delivery order contract with a performance period through May 3, 2024. Amerisourcebergen Drug Corp also holds a $999,999,999.00 indefinite...
- This federal contract award, valued at $5,290.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for GEL-ONE 30 MG/3 ML SYRINGE 3ML, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for...
- This federal contract award, SPE2DX15D3404|SPE2DX24F1BKJ, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies, with a ceiling value of $3,527.20 and a completion date of May 16, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,170.72, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a period of performance through November 15, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies, with a ceiling value of $3,649.00. The contract is a firm fixed price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a ceiling value of $5,290.80. The contract has a firm fixed price pricing type and an ultimate completion date of May 24, 2024. This appears to be a delivery order issued against...
- This federal contract award, valued at $3,649.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of December 11, 2024. This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $5,473.50 and a completion date of January 3, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPR49Delivery Order
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FPR49, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corporation (AmerisourceBergen), through its Corporate Office division located in Conshohocken, Pennsylvania. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a ceiling value of $13,050.64 and a performance period ending on April 4, 2024. This award is associated with a larger indefinite delivery contract (IDC) vehicle, also held by AmerisourceBergen, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. There is no set-aside designation for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 3/14/24 |